In The News
The AHEAD Study team is testing a new investigational treatment, examining whether they can slow or stop the earliest brain changes due to Alzheimer’s disease in people with a higher risk of developing the disease later in life. The team is seeking volunteers on its website. KATU 2 Portland, June 15, 2021
Hoag’s Pickup Family Neurosciences Institute in Newport Beach has started the AHEAD Study, which is recruiting people as young as 55 years old who are at risk of developing symptoms of Alzheimer’s as they age. Orange County Register, June 7, 2021
Dr. Reisa Sperling joined the show to recruit participants for the AHEAD Study, a clinical trial that aims to prevent Alzheimer's and create treatments that work for all patients. WDUN Radio, June 3, 2021
The Alzheimer’s Therapeutic Research Institute (ATRI) is seeking volunteers in Imperial County. The Desert Review, June 16, 2021
Individuals between the ages 55-80 who are not currently dealing with memory issues are sought to join the AHEAD Study by participating or volunteering at more than 70 sites across the U.S. and Canada, including Dallas-Fort Worth. News Radio 1080 KRLD, June 3, 2021
Among the top ten causes of death in the United States, Alzheimer's is the only one that cannot be prevented, cured or slowed, but ongoing clinical trials across the country, including at UAB, are working to change that. WVTM NBC 13 Birmingham, May 26, 2021
Researchers at the University of South Florida Byrd Alzheimer's Center and Research Institute are enrolling people for the AHEAD Study. ABC Action News Tampa Bay, March 26, 2021
Improved diagnostics, new ideas for prevention, and perhaps finally a drug for the disease. Boston Globe, October 29, 2020
After cases began emerging worldwide, thousands of clinical trials unrelated to COVID-19 were paused or canceled amid fears that participants would be infected. But now some researchers are finding ways to carry on in spite of the coronavirus. National Public Radio, October 20, 2020.
Researchers at the University of South Florida are participating in a national study to prevent Alzheimer’s before it hits. Tampa Bay Times, September 30, 2020.
The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced. September 25, 2020.
An Attleboro man has become the first in the world to take part in groundbreaking Alzheimer's research. WJAR, September 23, 2020.
Kalberer sees himself as a salesman for something that could help millions: participating in Alzheimer’s research. Providence Journal, September 23, 2020.
New study initiated in the U.S. for people who have intermediate or elevated levels of amyloid in their brains. Eisai, July 14, 2020.
Researchers at Butler and Rhode Island Hospitals will participate in a new clinical trial of an antibody that has shown potential to help rid the brain of beta-amyloid, a protein associated with Alzheimer’s disease. Providence Journal, July 14, 2020.
- All News